Oligonucleotide therapeutics for hematologic disorders.

Oligonucleotide therapeutics for hematologic disorders.

Item
http://www.wikidata.org/entity/Q33916119
Subcellular daunorubicin distribution and its relation to multidrug resistance phenotype in drug-resistant cell line SMMC-7721/R.Phase I study of GTI-2040, an antisense to ribonucleotide reductase, in combination with high-dose cytarabine in patients with acute myeloid leukemia.Biospecific interaction analysis: a tool for drug discovery and development.Phase I study of GTI-2040, a ribonucleotide reductase antisense, with high dose cytarabine in patients with relapsed/refractory acute myeloid leukemia.The quest for an efficacious antiviral for respiratory syncytial virus.In vivo imaging with oligonucleotides for diagnosis and drug development.ETS transcription factors: possible targets for cancer therapy.The significance of TP53 in lymphoid malignancies: mutation prevalence, regulation, prognostic impact and potential as a therapeutic target.Inhibitory Effects of Bangladeshi Medicinal Plant Extracts on Interactions between Transcription Factors and Target DNA Sequences.Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.
P2860

Oligonucleotide therapeutics for hematologic disorders.

Item
http://www.wikidata.org/entity/Q33916119
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Oligonucleotide therapeutics for hematologic disorders.
@ast
Oligonucleotide therapeutics for hematologic disorders.
@en
type
label
Oligonucleotide therapeutics for hematologic disorders.
@ast
Oligonucleotide therapeutics for hematologic disorders.
@en
prefLabel
Oligonucleotide therapeutics for hematologic disorders.
@ast
Oligonucleotide therapeutics for hematologic disorders.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Oligonucleotide therapeutics for hematologic disorders.
@en
P2093
P304
P31
P356
10.1016/S0167-4781(99)00142-6
P407
P433
P478
P577
P698